Loading…
INBISTRA is a consultancy that transforms biopharma science into fundable assets and profitable investments by combining operational drug discovery excellence with advanced financial modeling. The firm supports founders, scaleup biotechs, investors, and academic institutions through services like portfolio valuation, asset scouting, and translational frameworks to optimize development and capital deployment.
AI named INBISTRA in December 2025.